Trial reportNeurology2026
Visit-to-Visit Blood Pressure Variability and Cerebral White Matter Lesion Progression: A Pooled Individual Patient Data Analysis of 2 Trials.
Trial report in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesVisit-to-visit blood pressure variability (BPV) may contribute to cerebral white matter lesions (WML) progression, but previous evidence has been inconsistent and limited by methodological heterogeneity. This study aimed to assess the association between BPV and WML progression and its mediating role in the neuroprotective effects of intensive blood pressure (BP) control.
methodsThis post hoc individual participant data pooled analysis included the MRI substudies of ACCORD MIND and SPRINT MIND. Participants were eligible if they had both baseline and follow-up MRI scans and at least 3 BP measurements from the 3-month visit onward. Systolic BPV was calculated using multiple indices, with variation independent of mean (VIM) prespecified as the primary metric. WML progression was quantified as absolute and annualized changes in abnormal white matter (AWM) volume, with inverse hyperbolic sine (asinh)-transformed total change as the primary metric. Associations between systolic BPV and AWM volume changes were examined using multivariable linear regression, and causal mediation analysis assessed whether systolic BPV mediated the effects of intensive BP control.
resultsA total of 952 participants (mean age 64.8 years [SD 7.1]; 400 [42%] women) were included, contributing a median of 12 (interquartile range 10-14) BP measurements. Median AWM volume increased from 1.69 mL to 2.58 mL (0.43 mL per year [SD 0.84]). Higher systolic BPV was independently associated with faster AWM volume progression (β = 0.017, 95% CI 0.001 to 0.033). In raw annualized terms, participants in the highest tertile of SBP-VIM had 0.160 mL/y faster AWM progression than those in the lowest tertile. Intensive BP control was associated with slower AWM volume progression (β = -0.270, 95% CI -0.393 to -0.146). Mediation analysis indicated that systolic BPV partially mediated the association between intensive BP control and reduced AWM volume progression (average causal mediation effect 0.014, 95% CI 0.001-0.034), accounting for 9.15% of the total effect. DISCUSSION: Higher visit-to-visit systolic BPV was independently associated with faster WML progression. The benefit of intensive BP lowering on white matter integrity was partly mediated by reduced BPV, suggesting BP stability as a modifiable target to prevent white matter injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.